Description
Detection of antibodies to the nicotinic acetylcholine receptor in the blood, which are a sensitive and specific marker of myasthenia. They are observed in 80% of patients with myasthenia and are the main serological marker of this disease, used in the differential diagnosis of all neuromuscular pathologies. There is a high need for such testing among practicing neurologists.
Period of execution
Within 9 days. The specified time does not include the day of biomaterial collection
Biomaterial type